184 related articles for article (PubMed ID: 29263225)
1. Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child.
Nikolaus M; Jackowski-Dohrmann S; Prüss H; Schuelke M; Knierim E
Neurology; 2018 Jan; 90(4):183-185. PubMed ID: 29263225
[No Abstract] [Full Text] [Related]
2. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.
van Sonderen A; Petit-Pedrol M; Dalmau J; Titulaer MJ
Nat Rev Neurol; 2017 May; 13(5):290-301. PubMed ID: 28418022
[TBL] [Abstract][Full Text] [Related]
3. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
[TBL] [Abstract][Full Text] [Related]
4. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies.
Jia Y; Shi H; Ye J; Wang Y
Clin Neurol Neurosurg; 2020 Oct; 197():106187. PubMed ID: 32911250
[TBL] [Abstract][Full Text] [Related]
6. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
7. LGI1 and CASPR2 neurological autoimmunity in children.
López-Chiriboga AS; Klein C; Zekeridou A; McKeon A; Dubey D; Flanagan EP; Lennon VA; Tillema JM; Wirrell EC; Patterson MC; Gadoth A; Aaen JG; Brenton JN; Bui JD; Moen A; Otten C; Piquet A; Pittock SJ
Ann Neurol; 2018 Sep; 84(3):473-480. PubMed ID: 30076629
[TBL] [Abstract][Full Text] [Related]
8. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the clinical spectrum of CASPR2 antibody syndrome.
Boyko M; Au KLK; Casault C; de Robles P; Pfeffer G
J Neurol; 2020 Apr; 267(4):1137-1146. PubMed ID: 31912210
[TBL] [Abstract][Full Text] [Related]
10. LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.
Nosadini M; Toldo I; Tascini B; Bien CG; Parmeggiani L; De Gaspari P; Zuliani L; Sartori S
J Neuroimmunol; 2019 Oct; 335():577008. PubMed ID: 31352183
[TBL] [Abstract][Full Text] [Related]
11. Episodic ataxia in CASPR2 autoimmunity.
López Chiriboga AS; Pittock S
Neurol Neuroimmunol Neuroinflamm; 2019 Mar; 6(2):e536. PubMed ID: 30697586
[No Abstract] [Full Text] [Related]
12. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.
Binks SNM; Klein CJ; Waters P; Pittock SJ; Irani SR
J Neurol Neurosurg Psychiatry; 2018 May; 89(5):526-534. PubMed ID: 29055902
[TBL] [Abstract][Full Text] [Related]
13. Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
Vincent A; Pettingill P; Pettingill R; Lang B; Birch R; Waters P; Irani SR; Buckley C; Watanabe O; Arimura K; Kiernan MC
JAMA Neurol; 2018 Dec; 75(12):1519-1527. PubMed ID: 30242309
[TBL] [Abstract][Full Text] [Related]
14. Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.
Yeo T; Chen Z; Chai JYH; Tan K
J Neurol Sci; 2017 Jul; 378():85-90. PubMed ID: 28566186
[TBL] [Abstract][Full Text] [Related]
15. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.
van Sonderen A; Schreurs MW; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Autoimmun Rev; 2016 Oct; 15(10):970-4. PubMed ID: 27485013
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
17. Morvan syndrome: clinical and serological observations in 29 cases.
Irani SR; Pettingill P; Kleopa KA; Schiza N; Waters P; Mazia C; Zuliani L; Watanabe O; Lang B; Buckley C; Vincent A
Ann Neurol; 2012 Aug; 72(2):241-55. PubMed ID: 22473710
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Neurological Disorder with Anti-Ma2/Ta Antibodies in a Pediatric Patient.
Boniel S; Jeziorek A; Woźniak M; Lipińska E; Szczepanik E; Demkow U; Szymańska K
Isr Med Assoc J; 2018 Oct; 20(10):653-655. PubMed ID: 30324788
[No Abstract] [Full Text] [Related]
19. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.
Gadoth A; Pittock SJ; Dubey D; McKeon A; Britton JW; Schmeling JE; Smith A; Kotsenas AL; Watson RE; Lachance DH; Flanagan EP; Lennon VA; Klein CJ
Ann Neurol; 2017 Jul; 82(1):79-92. PubMed ID: 28628235
[TBL] [Abstract][Full Text] [Related]
20. Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2.
Bien CG
Front Immunol; 2018; 9():703. PubMed ID: 29696018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
